Our data indicate that suppressing K-RasG13D mutation in colon cancer cells with a pre-clinical G12C inhibitor S7333 can reduce the cell proliferation but promote their stemness including spheroid formation, stem marker CD133, K-Ras, and stem gene Lgr5 expressions. This evidence concerns the gene KRAS and malignant colon neoplasm.